• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利福霉素SV局部治疗滑膜炎——临床、关节镜及药理学评估

Rifamycin SV in local treatment of synovitis--a clinical, arthroscopic and pharmacologic evaluation.

作者信息

Lindblad S, Hedfors E, Malmborg A S

出版信息

J Rheumatol. 1985 Oct;12(5):900-3.

PMID:4087269
Abstract

Intraarticular injections of rifamycin SV were repeated weekly in patients with rheumatic disease with a chronic knee joint effusion. The clinical signs of synovitis were reduced in all, but disappeared in only one. A post injection reaction with transient local pain and effusion appeared at the third or a later injection in all the patients prompting withdrawal of 3. At these later injections local drug retention was shown by parallel determinations of rifamycin SV in synovial fluid and serum. The post treatment synovial fibrosis seen at arthroscopy could possibly explain the drug retention and the post injection inflammatory reaction. Thus, local treatment with rifamycin SV alleviated but rarely abolished synovitis.

摘要

对于患有慢性膝关节积液的风湿性疾病患者,每周重复进行关节内注射利福霉素SV。所有患者的滑膜炎临床症状均有所减轻,但只有1例症状消失。所有患者在第三次或之后的注射时出现了伴有短暂局部疼痛和积液的注射后反应,促使3例患者停药。在这些后续注射时,通过同步测定滑液和血清中的利福霉素SV显示存在局部药物潴留。关节镜检查时发现的治疗后滑膜纤维化可能解释了药物潴留和注射后炎症反应。因此,利福霉素SV局部治疗可减轻滑膜炎,但很少能将其消除。

相似文献

1
Rifamycin SV in local treatment of synovitis--a clinical, arthroscopic and pharmacologic evaluation.利福霉素SV局部治疗滑膜炎——临床、关节镜及药理学评估
J Rheumatol. 1985 Oct;12(5):900-3.
2
Rifamycin SV in the local treatment of synovitis.利福霉素SV在滑膜炎局部治疗中的应用
J Rheumatol. 1987 Feb;14(1):178-9.
3
Rheumatoid knee synovitis successfully treated with intra-articular rifamycin SV.关节腔内注射利福霉素SV成功治疗类风湿性膝关节滑膜炎
Ann Rheum Dis. 1982 Jun;41(3):232-6. doi: 10.1136/ard.41.3.232.
4
Rifamycin SV versus triamcinolone in local treatment of rheumatoid synovitis.利福霉素SV与曲安奈德在类风湿性滑膜炎局部治疗中的对比
Scand J Rheumatol. 1993;22(4):194-8. doi: 10.3109/03009749309099270.
5
[Rifamycin and superoxide dismutase in the treatment of rheumatoid synovitis of the knee].[利福霉素与超氧化物歧化酶治疗膝关节类风湿性滑膜炎]
Recenti Prog Med. 1985 May;76(5):265-8.
6
Changes in synovial membrane and joint effusion volumes after intraarticular methylprednisolone. Quantitative assessment of inflammatory and destructive changes in arthritis by MRI.关节内注射甲基强的松龙后滑膜和关节积液量的变化。通过MRI对关节炎的炎症和破坏性变化进行定量评估。
J Rheumatol. 1996 Jul;23(7):1151-61.
7
Intra-articular injection of high molecular weight hyaluronan after arthrocentesis as treatment for rheumatoid knees with joint effusion.关节穿刺后关节腔内注射高分子量透明质酸治疗类风湿性膝关节伴关节积液。
Rheumatol Int. 2002 Aug;22(4):151-4. doi: 10.1007/s00296-002-0214-y. Epub 2002 Jun 26.
8
Transsynovial kinetics of lonazolac and its hydroxy metabolite in synovitis patients.洛那唑酸及其羟基代谢物在滑膜炎患者中的经滑膜动力学
Int J Clin Pharmacol Ther. 1998 Aug;36(8):418-24.
9
[Rheumatoid synovitis of the knee, treated successfully with intra-articular rifamycin SV].膝关节类风湿性滑膜炎,关节腔内注射利福霉素SV治疗成功
Minerva Pediatr. 1982 Jan 31;34(1-2):33-7.
10
Chemotactic behaviour of peripheral and synovial neutrophils during rifamycin SV therapy in rheumatoid arthritis.
J Clin Lab Immunol. 1984 Jun;14(2):111-4.

引用本文的文献

1
Vaccination with endosomal unknown epitopes produces therapeutic response in rheumatoid arthritis patients and modulates adjuvant arthritis of rats.用内体未知表位进行疫苗接种可使类风湿性关节炎患者产生治疗反应,并调节大鼠的佐剂性关节炎。
J Transl Med. 2016 Jun 7;14(1):162. doi: 10.1186/s12967-016-0908-7.
2
3-(Carboxyalkylthio) rifamycin S and SV derivatives inhibit human neutrophil functions.3-(羧基烷硫基)利福霉素S和SV衍生物抑制人类中性粒细胞功能。
Inflammation. 1998 Oct;22(5):459-69. doi: 10.1023/a:1022341909396.
3
Rifamycins inhibit human neutrophil functions: new derivatives with potential antiinflammatory activity.
利福霉素抑制人类中性粒细胞功能:具有潜在抗炎活性的新衍生物。
Inflammation. 1997 Aug;21(4):391-400. doi: 10.1023/a:1027314419843.